Neoadjuvant therapy

Cancer Journal from Scientific American

Volumn 2, Issue 3, 1996, Pages 126-131

  Forastiere, Arlene A ^a   Urba, Susan G ^b   Liggett, William ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; ARTICLE; CLINICAL TRIAL; HUMAN; NEOPLASM;

ANTINEOPLASTIC AGENTS; CHEMOTHERAPY, ADJUVANT; CLINICAL TRIALS; HUMANS; NEOADJUVANT THERAPY; NEOPLASMS;

EID: 0000261081     PISSN: 10814442     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (32)

1. Bacci G, Picci P, Pignatti G et al. Neoadjuvant chemotherapy for nonmetastatic osteosarcoma of the extremities. Clin Orthop Rel Res 1991;270:89-98.
2. The Department of Veterans Affairs Laryngeal Cancer Study Group. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med 1991;324:1685-1690.
3. Wolf G, Hong W, Fisher S, Spaulding M et al. VA Laryngeal Cancer Study Group: Larynx preservation with induction chemotherapy (CT) and radiation (XRT) in advanced laryngeal cancer: final results of the VA Laryngeal Cancer Study Group Cooperative Trial. Proc Am Soc Clin Oncol 1993;12:277.
4. Kaufman DS, Shipley WU, Griffin PP et al. Selective bladder preservation by combination treatment of invasive bladder cancer. N Engl J Med 1993;329:1377-1382.
5. Tester W, Caplan R, Heaney J et al. Neoadjuvant combined modality program with selective organ preservation for invasive bladder cancer: results of Radiation Therapy Oncology Group Phase II Trial 8802. J Clin Oncol 1996;14:119-126.
6. Fisher B, Gunduz N, Saffer EA. Influence of the interval between primary tumor removal and chemotherapy on kinetics and growth of metastases. Cancer Res 1983;43:1488-1492.
7. Gunduz N, Fisher B, Saffer E. Effect of surgical removal on the growth and kinetics of residual tumor. Cancer Res 1979;39:1361-1365.
8. Logothetis C, Swanson D, Amato R et al. Optimal delivery of perioperative chemotherapy: Preliminary results of a randomized, prospective comparative trial of pre- and post-operative chemotherapy for invasive bladder cancer. J Urol 1996: in press.
9. Thrasher JB, Crawford ED. Current management of invasive and metastatic transitional cell carcinoma of the bladder. J Urol 1993;149:957-972.
10. Norton L, Day R Potential innovations in scheduling of cancer chemotherapy. In: DeVita VT, Hellman S, Rosenberg SA, eds. Important Advances in Oncology 1991. Philadelphia: J.B. Lippincott, 1991:57-73.
11. Schultz PK, Herr HW, Zhang ZF, Bajorin DF et al. Neoadjuvant chemotherapy for invasive bladder cancer: prognostic factors for survival of patients treated with M-VAC with 5-year follow-up. J Clin Oncol 1994;12:1394-1401.
12. Esrig D, Elmajian D, Groshen S et al. Accumulation of nuclear p53 and progression in bladder cancer. N Engl J Med 1994; 331:1259-1264.
13. Sarkis AS, Bajorin DF, Reuter VE et al. Prognostic value of p53 nuclear overexpression in patients with invasive bladder cancer treated with neoadjuvant M-VAC. J Clin Oncol 1995;13:1384-1390.
14. Spaulding MB, Fischer SG, Wolf GT et al. Tumor response, toxicity, and survival after neoadjuvant organ-preserving chemotherapy for advanced laryngeal cancer. J Clin Oncol 1994;12:1592-1599.
15. Tio TL, Coene PP, Luiken GJ et al. Endosonography in the clinical staging of esophagogastric carcinoma. Gastrointest Endosc 1990;36:S2-S10.
16. Herr H, Whitmore W, Morse M et al. Neoadjuvant chemotherapy in invasive bladder cancer. The evolving role of surgery. J Urol 1990;144:1083-1088.
17. Stupp R, Weichselbaum RR, Vokes EE. Combined modality therapy of head and neck cancer. Semin Oncol 1994;21:349-358.
18. Flood WA, Forastiere AA. Esophageal cancer. Curr Opin Oncol 1995;7:381-386.
19. Herskovic A, Martz K, Al-Sarraf M et al. Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med 1992;326:1593-1598.
20. Forastiere AA, Orringer MB, Perez-Tamayo C, Urba SG, Zahurak M. Preoperative chemoradiation followed by transhiatal esophagectomy for carcinoma of the esophagus: final report. J Clin Oncol 1993;11:1118-1123.
21. Forastiere AA, Heitmiller R, Lee DJ, Abrams R, Zahurak M. A 4-week intensive preoperative chemoradiation program for local-regional cancer of the esophagus. Proc Am Soc Clin Oncol 1994;13:195.
22. Urba S, Orringer M, Turrisi A et al. A randomized trial comparing transhiatal esophagectomy (THE) to preoperative concurrent chemoradiation followed by esophagectomy in local-regional esophageal carcinoma. Proc Am Soc Clin Oncol 1995;14:475.
23. Vokes EE, Weichselbaum RR. Concomitant chemoradiotherapy: Rationale and clinical experience in patients with solid tumors. J Clin Oncol 1990;8:911-934.
24. Nigro ND. Multidisciplinary management of cancer of the anus. World J Surg 1987;11:446-451.
25. Laramore GE, Scott CB, Al-Sarraf M et al. Adjuvant chemotherapy for resectable squamous cell carcinomas of the head and neck: report on intergroup study 0034. Int J Radiat Oncol Biol Phys 1992;23:705-713.
26. Nawroz H, van der Riet P, Hrubar R et al. Allelotype of head and neck squamous cell carcinoma. Cancer Res 1994;54:1152-1155.
27. Mao L, Lee DJ, Tockman MS et al. Micro satellite alterations as colonal markers for the detection of hunar cancer. Proc Natl Acad Sci USA 1994;91:9871-9875.
28. Moto A, Gabrielson E, Askin F et al. Frequent loss of chromosome 9 in human primary non-small cell lung cancer. Cancer Res 1994;54:640-642.
29. Mao L, Schoenberg M, Scicchitaro M et al. Molecular detection of primary bladder cancer by Micro satellite analysis. Science 1996;271:659-662.
30. Boyle J, Mao L, Brennan J et al. Gene mutations in saliva as molecular markers for head and neck squamous cell carcinomas. Am J Surgery 1994;168:429-432.
31. Mao L, Hruban R, Boyle J et al. Detection of oncogene mutations in sputan precedes diagnosis of lung cancer. Cancer Res 1994;54:1634-1637.
32. Brennan JA, Mao L, Hruban RH, Boyle JO et al. Molecular assessment of histopathological staging in squamous cell carcinoma of the head and neck. N Engl J Med 1995;332:429-435.